INAB
Income statement / Annual
Last year (2025), IN8bio Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, IN8bio Inc's net income was -$19.44 M.
See IN8bio Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$2.50 M
|
$0.00
|
$2.50 M
|
$0.00
|
$0.00
|
$0.00
|
$96.00 K
|
$96.00 K
|
| Gross Profit |
-$2.50 M
|
$0.00
|
-$2.50 M
|
$0.00
|
$0.00
|
$0.00
|
-$96.00 K
|
-$96.00 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$10.21 M
|
$16.96 M
|
$16.83 M
|
$14.06 M
|
$7.35 M
|
$5.38 M
|
$2.36 M
|
$581.00 K
|
| General & Administrative Expenses |
$9.65 M
|
$12.64 M
|
$13.51 M
|
$14.46 M
|
$7.31 M
|
$3.18 M
|
$2.71 M
|
$1.42 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$9.65 M
|
$12.64 M
|
$13.51 M
|
$14.46 M
|
$7.31 M
|
$3.18 M
|
$2.71 M
|
$1.42 M
|
| Other Expenses |
-$2.50 M
|
$838.00 K
|
-$2.50 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$63.00 K
|
| Operating Expenses |
$17.36 M
|
$30.44 M
|
$27.84 M
|
$28.52 M
|
$14.65 M
|
$8.56 M
|
$5.07 M
|
$2.00 M
|
| Cost And Expenses |
$19.86 M
|
$30.44 M
|
$30.34 M
|
$28.52 M
|
$14.65 M
|
$8.56 M
|
$5.07 M
|
$2.00 M
|
| Interest Income |
$421.00 K
|
$230.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$14.00 K
|
| Depreciation & Amortization |
$2.50 M
|
$2.66 M
|
$2.50 M
|
$1.10 M
|
$788.00 K
|
$88.00 K
|
$96.00 K
|
$96.00 K
|
| EBITDA |
-$17.36 M |
-$26.94 M |
-$27.51 M |
-$27.42 M |
-$13.87 M |
-$8.47 M |
-$5.04 M |
-$1.97 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$421.00 K
|
$0.00
|
$330.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$77.00 K
|
| Income Before Tax |
-$19.44 M
|
-$30.44 M
|
-$30.01 M
|
-$28.52 M
|
-$14.65 M
|
-$8.56 M
|
-$5.13 M
|
-$2.08 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$19.44 M
|
-$30.44 M
|
-$30.01 M
|
-$28.52 M
|
-$14.65 M
|
-$8.56 M
|
-$5.13 M
|
-$2.08 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-4.44 |
-0.57 |
-1 |
-1.36 |
-0.78 |
-0.53 |
-0.27 |
-0.11 |
| EPS Diluted |
-4.44 |
-0.57 |
-1 |
-1.36 |
-0.78 |
-0.53 |
-0.27 |
-0.11 |
| Weighted Average Shares Out |
$4.37 M
|
$53.55 M
|
$29.87 M
|
$20.97 M
|
$18.78 M
|
$19.35 M
|
$19.35 M
|
$19.35 M
|
| Weighted Average Shares Out Diluted |
$4.37 M
|
$53.55 M
|
$29.87 M
|
$20.97 M
|
$18.78 M
|
$19.35 M
|
$19.35 M
|
$19.35 M
|
| Link |
|
|
|
|
|
|
|
|
